Vitamin B3 May Help Reduce Risk of Certain Skin Cancers

Vitamin B3 May Help Reduce Risk of Certain Skin Cancers

A study presented at the American Society of Clinical Oncology’s (ASCO) 51st Annual Meeting found that an over-the-counter form of vitamin B3 significantly reduced rates of new non-melanoma skin cancers in high-risk patients, which along with sun protection could help to decrease the health and economic burden of skin cancer. The Oral nicotinamide (vitamin B3) to Reduce actinic Cancer (ONTRAC) Study consisted of a double-blind randomized controlled trial (RCT) of 386 patients in two tertiary centers in Sydney, Australia from 2012–2014 who had received two or more confirmed diagnoses of non-melanoma skin cancers in the past five years. Patients received oral nicotinamide (B3) 500mg twice a day or placebo for 12 months; mean patient age was 66 years and two-thirds of the participants were male. The primary endpoint was the number of new non-melanoma skin cancers and secondary endpoints included the number of squamous cell carcinomas (SCCs), basal cell carcinomas (BCCs), and actinic keratoses (AKs).

By | 2019-01-08T10:21:17+00:00 July 7th, 2015|News|0 Comments

About the Author:

Leave A Comment

CallEmail GalleryDirections
Call